Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Education Library
  3. ESMO Webinars
  4. ESMO Deep Dive: Lung Cancer - Webinar Series

ESMO Deep Dive: Lung Cancer - Non-metastatic NSCLC - Multidisciplinary State of the Art 2025

Aired live on 05 Mar 2025

ESMO-Webinar-Deep-Dive-1000x1000

This content is for ESMO members only.

Login

Learn more about how you can join ESMO

Presentation

Download slides

Programme

  • 5 March 2025
Welcome and introduction
Enriqueta Felip
Surgery – controversies and challenges
Jonathan Spicer
Radiation – opportunities, future directions
Corinne Finn
Systemic therapy – key challenges moving from trials into practice
Federico Cappuzzo
QnA and Discussion
All speakers

Description

This ESMO Deep Dive Lung Cancer Webinar focused on Non-metastatic NSCLC – Multidisciplinary State of the Art.

This webinar was developed with the aim to provide a second, deeper layer of educational experience in emerging data related to: molecular biology and classification, translational research and biomarkers for precision medicine, and unknowns, hypotheses, and ongoing research in areas of controversy or unmet need for optimal management of patients.

It began with a welcome and introduction, followed by lectures covering surgery controversies and challenges, opportunities and future directions in radiation, and key challenges in translating systemic therapy from trials to practice. The webinar ended with a discussion with the panel and a live Q&A session.

This programme is designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with lung cancers, offer expert opinion exchange and provide some important considerations in this field.

Learning objectives

  • To acquire a deeper understanding of the clinical course of malignant disease of lung cancer. ​
  • To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for lung cancer.​
  • To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies.​
  • To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects.

Supported by

This ESMO product is supported by unrestricted educational grants.

SB-Boehringer-Ingelheim-Light-Green
SB-Daiichi Sankyo
SB-Gilead
SB-Johnson-and-Johnson
SB-Lilly
SB-Roche

The sponsors have had no control or influence on the content of the webinar.

You may also be interested in...

ESMO Deep Dive: Lung Cancer

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.